ERBB2 and neoplasm: Shou Liu et al. demonstrated that HER2+ overexpression promoted tumour-derived secretion of IL1a and IL6 which, in turn, induced the NF-kB and STAT3 pathways and led to the expansion of breast CSCs [73].